Listen to blog
Audio generated by AI
At a Glance
- New Research Focus: NIH and NIAID leaders propose a shift toward infectious diseases and immunology as core research priorities.
- Recognition of Post-Infectious Illness: The vision highlights conditions that can develop after infection, including:
- Long COVID
- ME/CFS
- Chronic Lyme disease
- Post-vaccination adverse events
- Emphasis on Immune System Research: Increased focus on how the immune system responds to infection—and how those responses may contribute to chronic illness.
- Relevance to ME/CFS & Long COVID:
- Reinforces long-standing evidence that infections can trigger lasting illness
- Supports research into immune dysregulation and chronic inflammation
- Broader Impact: May also explore links between infections and other chronic diseases (e.g., multiple sclerosis, type 1 diabetes).
- What This Means:
- Signals growing scientific recognition of post-infectious conditions
- Does not yet determine funding, but may influence future research priorities
- Why It Matters:
Increased attention at the federal level could help advance understanding and, ultimately, improve care for people living with ME/CFS, Long COVID, and related conditions.
NIH and NIAID Outline New Strategic Vision for Infectious Disease and Immunology Research
Leaders of the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID) recently published a comment in Nature Medicine outlining a proposed new strategic vision for the institute.
Increased Attention to Post-Infectious Illness
In the article, NIAID leadership states that the institute will support research aimed at better understanding long-term inflammatory and post-infectious illnesses. These are conditions that can develop or persist after an infection.
The authors specifically mention several conditions, including:
- Long COVID
- Chronic Lyme disease
- Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
- Adverse events following vaccination
They also note that infections may play a role in triggering or contributing to other chronic diseases, and that studying these connections may help scientists better understand immune system dysfunction.
For many people living with ME/CFS, this recognition reflects growing awareness of how infections can lead to long-lasting health effects.
A Shift Toward Immunology Research
The article describes a shift in how NIAID plans to organize its research priorities. Historically, NIAID has focused on three main areas: HIV research, biodefense and pandemic preparedness, and a broad category encompassing infectious, allergic, and immune-related diseases. Under the proposed framework, the institute would instead center its work around two core pillars:
- Infectious diseases affecting Americans today
- Immunology, including allergic and autoimmune diseases
Because many post-infectious illnesses involve changes in immune function, the authors argue that a stronger focus on immunology could help scientists better understand conditions that develop after infections.
The article also highlights the importance of studying how the immune system develops, how it responds to infection, and how those responses may sometimes contribute to chronic illness.
Why This Matters for Research into ME/CFS, Long COVID, and Related Infection Associated Chronic Conditions (IACCs)
For decades, people with ME/CFS have reported the onset of illness following viral or bacterial infections. Researchers have long suspected that immune dysregulation, chronic inflammation, and other biological changes may play a role in the condition.
The new NIAID vision identifies post-infectious inflammatory syndromes as an area of scientific interest. In addition to ME/CFS and long COVID, the authors suggest that research may explore how infections could influence the development of other chronic diseases, such as type 1 diabetes or multiple sclerosis.
This type of research may help scientists better understand how infections interact with the immune system and why some individuals develop long-term illness afterward.
Strategic vision statements outline research priorities, but they do not determine specific funding decisions or research programs. Those developments typically occur later through grant opportunities, research initiatives, and collaborations.
Because the article specifically references ME/CFS and other post-infectious conditions, we felt it important to share this update with our community. Bateman Horne Center will continue to follow developments related to federal research priorities that may affect the understanding and treatment of ME/CFS and related illnesses.
*The full article in Nature Medicine can be found here. (Please note, it is currently behind a paywall).
Lucinda Bateman, MD, is a renowned clinician, researcher, and educator. Her Johns Hopkins University Medical School training instilled an approach to care that she has employed throughout her career – the patient comes first and the unknown or unexplained does not equate to a lack of proper and compassionate care. Since starting her own practice in 2000, she has served on six boards or committees, been the principal investigator for 45 studies, authored/coauthored 40 journal articles, served as adjunct instructor and adjunct assistant professor in the University of Utah Departments of Preventative Medicine, Internal Medicine, and Anesthesiology, and lectured around the world.